Courtney E. Heron, BS, Rima I. Ghamrawi, BS, Steven R. Feldman, MD, PhD
The evolving pathogenesis and various phenotypic presentations of atopic dermatitis (AD) can guide research to important discoveries in immunotherapy and future therapies, highlighting a positive future in the treatment of AD.
Michael J. Visconti, BS, Arjun M. Bashyam, BA, Steven R. Feldman, MD, PhD, Amor Khachemoune, MD, FAAD, FACMS, Section Editor
A 16-year-old adolescent boy presented with a 2-year history of an expanding, dark eruption involving the chest, abdomen, axilla, and upper extremities. There was no pruritus or other associated symptom.
But, oh, how different it must be for the administrators of our department and medical center! With a situation in rapid flux, they are constantly having to modify our office procedures and staffing. People are being assigned and reassigned to new tasks weekly, if not daily.
With coronavirus disease (COVID-19), our generation is seeing a plague of what has been for us unprecedented proportions. The number of Americans who will die from it will be large. The economic impact of trying to minimize the effect of this scourge will be enormous. There will likely be resulting long-term shifts in how we organize our lives that will dwarf anything we have seen before.
There’s so much new out there, and this issue covers what’s new in social media (page 38), acne (page 50), and hyperhidrosis (page 42). It reminds me of an unsolicited email I received containing information about an exciting new treatment.
Farina’s observation sums up a critical point. Outliers are publicized and noticed; the everyday normal is often ignored. A quote (mis)ascribed to Mark Twain says it well too: “If you don’t read the newspaper, you’re uninformed. If you read the newspaper, you’re misinformed.”